IsoRay Shares Outstanding 2006-2019 | ISR

IsoRay shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
IsoRay Annual Shares Outstanding
(Millions of Shares)
2018 55
2017 55
2016 55
2015 55
2014 43
2013 34
2012 29
2011 25
2010 23
2009 23
2008 23
2007 18
2006 12
2005 5
IsoRay Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 67
Q2 2018 67
Q1 2018 66
Q4 2018 55
Q3 2018 55
Q2 2017 55
Q1 2017 55
Q4 2017 55
Q3 2017 55
Q2 2016 55
Q1 2016 55
Q4 2016 55
Q3 2016 55
Q2 2015 55
Q1 2015 55
Q4 2015 55
Q3 2015 55
Q2 2014 55
Q1 2014 55
Q4 2014 43
Q3 2014 43
Q2 2013 38
Q1 2013 36
Q4 2013 34
Q3 2013 35
Q2 2012 35
Q1 2012 34
Q4 2012 29
Q3 2012 29
Q2 2011 29
Q1 2011 26
Q4 2011 25
Q3 2011 26
Q2 2010 25
Q1 2010 23
Q4 2010 23
Q3 2010 23
Q2 2009 23
Q1 2009 23
Q4 2009 23
Q3 2009 23
Q2 2008 23
Q1 2008 23
Q4 2008 23
Q3 2008 23
Q2 2007 23
Q1 2007 23
Q4 2007 18
Q3 2007 17
Q2 2006 16
Q1 2006 15
Q4 2006 12
Q3 2006 15
Q2 2005 12
Q1 2005 9
Q4 2005 5
Q3 2005 7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.028B $0.006B
IsoRay, Inc. is a medical technology company that produces therapeutic radioactive isotopes. Through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device. The Company competes with Varian Medical Systems, Siemens Healthcare, Elekta AB and Accuray Incorporated.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.701B 34.95
Takeda Pharmaceutical (TAK) Japan $27.841B 8.17
Grifols (GRFS) Spain $13.524B 17.10
Sage Therapeutics (SAGE) United States $9.300B 0.00
Ionis Pharmaceuticals (IONS) United States $9.155B 20.01
Neurocrine Biosciences (NBIX) United States $7.798B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.576B 10.39
Catalent (CTLT) United States $7.372B 29.58
Nektar Therapeutics (NKTR) United States $6.160B 10.04
Tilray (TLRY) Canada $4.421B 0.00
FibroGen (FGEN) United States $3.838B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.489B 12.24
United Therapeutics (UTHR) United States $3.444B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.608B 393.00
PTC Therapeutics (PTCT) United States $2.507B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.028B 7.30
Xencor (XNCR) United States $1.953B 53.31
Portola Pharmaceuticals (PTLA) United States $1.903B 0.00
Tricida (TCDA) United States $1.847B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.802B 87.26
Ironwood Pharmaceuticals (IRWD) United States $1.788B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.773B 24.24
Zogenix (ZGNX) United States $1.714B 0.00
USANA Health Sciences (USNA) United States $1.681B 14.61
Madrigal Pharmaceuticals (MDGL) United States $1.620B 0.00
Aerie Pharmaceuticals (AERI) United States $1.510B 0.00
Heron Therapeutics (HRTX) United States $1.436B 0.00
Esperion Therapeutics (ESPR) United States $1.363B 0.00
Turning Point Therapeutics (TPTX) United States $1.297B 0.00
Corcept Therapeutics (CORT) United States $1.209B 17.26
Radius Health (RDUS) United States $1.127B 0.00
ArQule (ARQL) United States $1.058B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.945B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.944B 0.00
Endo (ENDP) Ireland $0.898B 1.44
Aptorum Group (APM) China $0.739B 0.00
CannTrust Holdings (CTST) Canada $0.733B 0.00
Odonate Therapeutics (ODT) United States $0.707B 0.00
Organogenesis Holdings (ORGO) United States $0.675B 0.00
TherapeuticsMD (TXMD) United States $0.654B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.583B 0.00
Translate Bio (TBIO) United States $0.571B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.560B 0.00
Dermira (DERM) United States $0.538B 0.00
Akebia Therapeutics (AKBA) United States $0.532B 0.00
ChemoCentryx (CCXI) United States $0.497B 0.00
GlycoMimetics (GLYC) United States $0.496B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.452B 22.80
Flexion Therapeutics (FLXN) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.435B 1.03
Collegium Pharmaceutical (COLL) United States $0.404B 0.00
TCR2 Therapeutics (TCRR) United States $0.400B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
Karyopharm Therapeutics (KPTI) United States $0.362B 0.00
KalVista Pharmaceuticals (KALV) United States $0.353B 0.00
Forty Seven (FTSV) United States $0.336B 0.00
Rafael Holdings (RFL) United States $0.335B 0.00
ImmunoGen (IMGN) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.306B 0.00
OptiNose (OPTN) United States $0.300B 0.00
Molecular Templates (MTEM) United States $0.296B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.294B 0.00
Harpoon Therapeutics (HARP) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.280B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.242B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.240B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.232B 0.00
Lannett Co Inc (LCI) United States $0.223B 2.17
Recro Pharma (REPH) United States $0.217B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.215B 0.00
Aclaris Therapeutics (ACRS) United States $0.211B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.204B 0.00
Bio Blast Pharma (ENLV) Israel $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.194B 0.00
Ocular Therapeutix (OCUL) United States $0.191B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.190B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Galectin Therapeutics (GALT) United States $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 57.38
Minerva Neurosciences (NERV) United States $0.175B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.172B 0.00
Opexa Therapeutics (ACER) United States $0.169B 0.00
Calithera Biosciences (CALA) United States $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.160B 0.00
Ardelyx (ARDX) United States $0.160B 0.00
IMV INC (IMV) Canada $0.157B 0.00
Redhill Biopharma (RDHL) Israel $0.154B 0.00
AgeX Therapeutics (AGE) United States $0.147B 0.00
Majesco Entertainment (PTE) United States $0.145B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.136B 0.00
Aquestive Therapeutics (AQST) United States $0.120B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.118B 0.00
Tyme Technologies (TYME) United States $0.113B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.112B 0.00
MediWound (MDWD) Israel $0.099B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Cardiome Pharma (CORV) Canada $0.097B 0.00
Mast Therapeutics (SVRA) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.78
DURECT (DRRX) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
Avenue Therapeutics (ATXI) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.092B 9.21
Iterum Therapeutics (ITRM) Ireland $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.090B 0.00
Capnia (SLNO) United States $0.087B 0.00
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
China SXT Pharmaceuticals (SXTC) China $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
Melinta Therapeutics (MLNT) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Novan (NOVN) United States $0.069B 0.00
Neos Therapeutics (NEOS) United States $0.065B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.054B 0.00
KemPharm (KMPH) United States $0.053B 0.00
AIT Therapeutics (AITB) Israel $0.053B 0.00
Zafgen (ZFGN) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.049B 0.00
India Globalization Capital (IGC) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.042B 0.00
Bio-Path Holdings (BPTH) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
ContraFect (CFRX) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Regulus Therapeutics (RGLS) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.60
Pain Therapeutics (SAVA) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
PRECISION THERAPEUTICS INC (POAI) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00